Framework Journal · one stock, one dated entry

Recorded 2026-07-19 · Permanent

Jin Medical International Ltd ZJYL

Clears the common standard

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · Jin Medical International Ltd.

The label
Markup

read at $1.90

Jin Medical International Ltd holds its Markup at $1.90.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markup label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · passes the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-07-19
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 2 days
Price$1.90
Valuation9.50 trailing · N/A forward price to earnings
Values screenPASS · score 70.0
Beta7.34

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Trailing P/E9.5x
very cheap relative to earnings
Revenue growth-16.5%
revenue is shrinking
Profit margin5.8%
thin but positive margins
Return on equity4.8%
a modest return on shareholder capital
Debt to equity0.64
moderate, manageable leverage
Current ratio1.86
healthy short-term liquidity
Beta7.34
much more volatile than the market
Market cap$15M
Employees273

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to China and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Related securities · others in ZJYL's space worth a look

RGNT Regentis Biomaterials Ltd BNGO Bionano Genomics Inc RVP Retractable Technologies Inc CUPR Cuprina Holdings (Cayman) Ltd FEMY Femasys Inc HBIO Harvard Bioscience Inc

Screened names in the same industry · explore each on its own page.

The trader read · the latest dated commentary

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 19%. Entered 2026-07-18 · Markup

The dated journal · newest first, never edited

2026-07-18 Markup $2.42 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-07-03 Markup $2.42 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Markup $2.42 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2.33 +1.3% · $1,013 +1.3%
2 months $2.31 +2.2% · $1,022 +2.2%
3 months $2.32 +1.7% · $1,017 +1.7%
6 months $4.38 -46.1% · $539 -46.1%
1 year $13.40 -82.4% · $176 -82.4%
2 years $57.20 -95.9% · $41 -95.9%
3 years $8.53 -72.3% · $277 -72.3%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever ZJYL does next, these words stay.

Jin Medical International Ltd · ZJYL · Markup · $1.90
Recorded 2026-07-19 · before the outcome · scored mechanically

All of today's entries See the running score

Get our weekly market brief free.